DEZHAN HEALTHCARE(000813) Xin Lang Cai Jing·2025-04-30 01:05Core Viewpoint - 德展健康's Q1 2025 financial report shows a decline in revenue and net profit, indicating challenges in the current market environment [1][3] Financial Performance - The company's total revenue for Q1 2025 was 89.28 million yuan, ranking 131 among peers, a decrease of 11.82% year-on-year [1] - The net profit attributable to shareholders was -22.11 million yuan, ranking 136 among peers, a decline of 530.98 thousand yuan compared to the same period last year [1] - Operating cash flow was 18.04 million yuan, ranking 80 among peers, down 20.60% year-on-year [1] Financial Ratios - The latest debt-to-asset ratio is 4.11%, ranking 2 among peers, an increase of 1.20 percentage points from the previous quarter and 1.30 percentage points from the same period last year [3] - The gross profit margin is 59.82%, ranking 54 among peers, a decrease of 4.31 percentage points from the previous quarter but an increase of 8.25 percentage points year-on-year [3] - Return on equity (ROE) is -0.43%, ranking 125 among peers, a decrease of 0.11 percentage points year-on-year [3] Earnings Per Share and Turnover Ratios - The diluted earnings per share is -0.01 yuan, ranking 122 among peers, remaining stable compared to the same period last year [3] - The total asset turnover ratio is 0.02 times, ranking 150 among peers, unchanged from the previous year but down 11.64% year-on-year [3] - The inventory turnover ratio is 0.18 times, ranking 144 among peers, a decrease of 0.06 times compared to the previous year, down 26.78% year-on-year [3] Shareholder Structure - The number of shareholders is 65,400, with the top ten shareholders holding 1.201 billion shares, accounting for 55.46% of the total share capital [3] - The largest shareholder is 上海岳野股权投资管理合伙企业(有限合伙) with a holding of 19.13% [3]